Published December 1996 | Version v1
Journal article Metadata-only

Ir-192 high dose rate interstitial brachytherapy for recurrent breast cancer

Creators

  • 1. Japanese Foundation for Cancer Research, Tokyo (Japan). Hospital

Description

Eight patients with recurrent breast cancer were treated with Ir-192 high dose rate interstitial brachytherapy. Seven of eight were loco-regional chest wall recurrence and one was axillary lymph node metastasis. Interstitial brachytherapy doses at the point 5 mm from the applicator plane were from 5 to 20 Gy. Seven of eight were treated after external beam irradiation of 40-62 Gy. Treatment time was once or twice. Local control rate was 87.5%. No serious side effects were observed. It was considered Ir-192 high dose rate interstitial brachytherapy is effective for palliation of recurrent breast cancer patients. (author)

Additional details

Publishing Information

Journal Title
Rinsho Hoshasen
Journal Volume
41
Journal Issue
13
Journal Page Range
p. 1639-1642.
ISSN
0009-9252
CODEN
RHOSAM

INIS

Country of Publication
Japan
Country of Input or Organization
Japan
INIS RN
28025743
Subject category
S62: RADIOLOGY AND NUCLEAR MEDICINE;
Descriptors DEI
CARCINOMAS; COMBINED THERAPY; EXTERNAL IRRADIATION; INTERNAL IRRADIATION; IRIDIUM 192; MAMMARY GLANDS; PATHOLOGICAL CHANGES; PATIENTS; RADIATION DOSES; RADIATION SOURCE IMPLANTS; RADIOTHERAPY
Descriptors DEC
ANIMALS; BETA DECAY RADIOISOTOPES; BETA-MINUS DECAY RADIOISOTOPES; BODY; DAYS LIVING RADIOISOTOPES; DISEASES; ELECTRON CAPTURE RADIOISOTOPES; GLANDS; HEAVY NUCLEI; IMPLANTS; INTERNAL CONVERSION RADIOISOTOPES; IRIDIUM ISOTOPES; IRRADIATION; ISOMERIC TRANSITION ISOTOPES; ISOTOPES; MAMMALS; MAN; MEDICINE; MINUTES LIVING RADIOISOTOPES; NEOPLASMS; NUCLEI; ODD-ODD NUCLEI; ORGANS; PRIMATES; RADIATION SOURCES; RADIOISOTOPES; THERAPY; VERTEBRATES; YEARS LIVING RADIOISOTOPES